Current Issue - November 2022, Volume 16, Issue No. 3

1. Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect. 2017; 96(1): 1-15. doi: 10.1016/j.jhin.2017.03.004
2. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013; 173(22): 2039-46. doi: 10.1001/jamainternmed.2013.9763
3. Centers for Disease Control and Prevention. National Healthcare Safety Network. Surgical Site Infection (SSI) Event, 2015. https://apic.org/Resource_/TinyMceFileManager/Academy/ASC_101_resources/Surveillance_NHSN/NHSN_9pscSSIcurrent_j an2015.pdf ) (last accessed 13 April 2020)
4. Zimmerli W, Sendi P. Orthopedic implant-associated infections. In: Mandell G, Dolin R, Bennett J, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia: Elsevier; 2020. p. 1430-42.
5. Bozic KJ, Lau E, Kurtz S, Ong K, Berry DJ. Patient-related risk factors for postoperative mortality and periprosthetic joint infection in medicare patients undergoing TKA. Clin Orthop Relat Res. 2012; 470(1): 130-7. doi: 10.1007/s11999-011-2043-3
6. Lee MK, Chiu CS, Chow VC, Lam RK, Lai RW. Prevalence of hospital infection and antibiotic use at a university medical center in Hong Kong. J Hosp Infect. 2007; 65(4): 341-7. doi: 10.1016/j.jhin.2006.12.013
7. Choong PF, Dowsey MM, Carr D, Daffy J, Stanley P. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen. Acta Orthop. 2007; 78(6): 755-65. doi: 10.1080/17453670710014527
8. Dowsey MM, Choong PF. Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty. Clin Orthop Relat Res. 2008; 466(1): 153-8. doi: 10.1007/s11999-007-0016-3
9. Gurunathan U, Ramsay S, Mitric G, Way M, Wockner L, Myles P. Association Between Obesity and Wound Infection Following Colorectal Surgery: Systematic Review and Meta-Analysis. J Gastrointest Surg. 2017; 21(10): 1700-12. doi: 10.1007/s11605-017-3494-y
10. George DA, Drago L, Scarponi S, Gallazzi E, Haddad FS, Romano CL. Predicting lower limb periprosthetic joint infections: A review of risk factors and their classification. World J Orthop. 2017; 8(5): 400-11. doi: 10.5312/wjo.v8.i5.400
11. Talbot TR. Diabetes mellitus and cardiothoracic surgical site infections. Am J Infect Control. 2005; 33(6): 353-9. doi: 10.1016/j.ajic.2004.10.008
12. Nolan MB, Martin DP, Thompson R, Schroeder DR, Hanson AC, Warner DO. Association Between Smoking Status, Preoperative Exhaled Carbon Monoxide Levels, and Postoperative Surgical Site Infection in Patients Undergoing Elective Surgery. JAMA Surg. 2017; 152(5): 476-83. doi: 10.1001/jamasurg.2016.5704. Erratum in: JAMA Surg. 2017; 152(5): 508.
13. Kessler B, Sendi P, Graber P, Knupp M, Zwicky L, Hintermann B, et al. Risk factors for periprosthetic ankle joint infection: a case-control study. J Bone Joint Surg Am. 2012; 94(20): 1871-6. doi: 10.2106/JBJS.K.00593
14. Leber AL, editor. Clinical microbiology procedures handbook. 4th ed. John Wiley & Sons; 2016.
15. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI supplement M100-S20. CLSI. 2020.
16. Centers for Disease Control and Prevention. National Healthcare Safety Network. Surgical Site Infection (SSI) Event, 2020. https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf (last accessed 8 March 2020)
17. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013; 56(1): e1-25. doi: 10.1093/cid/cis803
18. Center for Disease Control and Prevention. National Hospital Discharge Survey: Number and Rate of Discharges from Short-Stay Hospitals and of Days of Care, with Average Length of Stay and Standard Error, by Selected First-Listed Diagnostic Categories. 2010. http://www.cdc.gov/nchs/data/nhds/4procedures/2010pro4_numberrate.pdf (last accessed 25 January 2019)
19. Al-Mulhim FA, Baragbah MA, Sadat-Ali M, Alomran AS, Azam MQ. Prevalence of surgical site infection in orthopedic surgery: a 5-year analysis. Int Surg. 2014; 99(3): 264-8. doi: 10.9738/INTSURG-D-13-00251.1
20. Pruzansky JS, Bronson MJ, Grelsamer RP, Strauss E, Moucha CS. Prevalence of modifiable surgical site infection risk factors in hip and knee joint arthroplasty patients at an urban academic hospital. J Arthroplasty. 2014; 29(2): 272-6. doi: 10.1016/j.arth.2013.06.019
21. Rüedi TP, Buckley RE, Moran CG. AO Principles of Fracture Management. 2nd expanded ed. Stuttgart: Thieme. 2007.
22. Pull ter Gunne AF, Cohen DB. Incidence, prevalence, and analysis of risk factors for surgical site infection following adult spinal surgery. Spine (Phila Pa 1976). 2009; 34(13): 1422-8. doi: 10.1097/BRS.0b013e3181a03013
23. Dhillon KS, Kok CS. The incidence of post-operative wound infection in orthopaedic surgery. Med J Malaysia. 1995; 50(3): 237-40.
24. Tan LT, Shiang F, Wong J, Azmah Tuan Mat TN, Gandhi A. A Prospective Study of Surgical Site Infection in Elective and Emergency General Surgery in a Tertiary Public Hospital in Malaysia - A Preliminary Report. Madridge J Surg. 2019; 2(1): 52-8. doi: 10.18689/mjs-1000113
25. Talbot TR. Surgical site infections and antimicrobial prophylaxis. In: Mandell G, Dolin R, Bennett J, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia: Elsevier; 2020. p. 3743-3756.
26. Yuan K, Chen HL. Obesity and surgical site infections risk in orthopedics: a meta-analysis. Int J Surg. 2013; 11(5): 383-8. doi: 10.1016/j.ijsu.2013.02.018
27. Abdallah DY, Jadaan MM, McCabe JP. Body mass index and risk of surgical site infection following spine surgery: a meta-analysis. Eur Spine J. 2013; 22(12): 2800-9. doi: 10.1007/s00586-013-2890-6
28. Gronkjær M, Eliasen M, Skov-Ettrup LS, Tolstrup JS, Christiansen AH, Mikkelsen SS, et al. Preoperative smoking status and postoperative complications: a systematic review and meta-analysis. Ann Surg. 2014; 259(1): 52-71. doi: 10.1097/SLA.0b013e3182911913
29. Teng S, Yi C, Krettek C, Jagodzinski M. Smoking and risk of prosthesis-related complications after total hip arthroplasty: a meta-analysis of cohort studies. PLoS One. 2015; 10(4): e0125294. doi: 10.1371/journal.pone.0125294
30. Durand F, Berthelot P, Cazorla C, Farizon F, Lucht F. Smoking is a risk factor of organ/space surgical site infection in orthopaedic surgery with implant materials. Int Orthop. 2013; 37(4): 723-7. doi: 10.1007/s00264-013-1814-8
31. Sorensen LT. Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: a systematic review. Ann Surg. 2012; 255(6): 1069-79. doi: 10.1097/SLA.0b013e31824f632d
32. Viola J, Gomez MM, Restrepo C, Maltenfort MG, Parvizi J. Preoperative anemia increases postoperative complications and mortality following total joint arthroplasty. J Arthroplasty. 2015; 30(5): 846-8. doi: 10.1016/j.arth.2014.12.026
33. Greenky M, Gandhi K, Pulido L, Restrepo C, Parvizi J. Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection? Clin Orthop Relat Res. 2012; 470(10): 2695-701. doi: 10.1007/s11999-012-2435-z
34. Rohrer F, Maurer A, Noetzli H, Gahl B, Limacher A, Hermann T, et al. Prolonged antibiotic prophylaxis use in elective orthopaedic surgery - a cross-sectional analysis. BMC Musculoskelet Disord. 2021; 22(1): 420. doi: 10.1186/s12891-021-04290-w
35. Oh AL, Goh LM, Nik Azim NA, Tee CS, Shehab Phung CW. Antibiotic usage in surgical prophylaxis: a prospective surveillance of surgical wards at a tertiary hospital in Malaysia. J Infect Dev Ctries. 2014; 8(2): 193-201. doi: 10.3855/jidc.3076
36. Jamaluddin NAH, Periyasamy P, Lau CL, Ponnampalavanar S, Lai PSM, Ramli R, et al. Point Prevalence Survey of Antimicrobial Use in a Malaysian Tertiary Care University Hospital. Antibiotics (Basel). 2021; 10(5): 531. doi: 10.3390/antibiotics10050531
37. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. 2000; 101(25): 2916-21. doi: 10.1161/01.cir.101.25.2916
38. Ministry of Health Malaysia. National Antimicrobial Guideline (NAG) 2019, 3rd Edition. https://www.pharmacy.gov.my/v2/en/documents/national-antimicrobial-guideline-nag-2019-3rd-edition.html. (last accessed 21 December 2021)
39. Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt). 2013; 14(1): 73-156. doi: 10.1089/sur.2013.9999
40. Al-Talib HI, Yean CY, Al-Jashamy K, Hasan H. Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007. Ann Saudi Med. 2010; 30(5): 358-63. doi: 10.4103/0256-4947.67077
41. Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL. Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect. 2007; 55(1): 1-7. doi: 10.1016/j.jinf.2007.01.007
42. Benito N, Franco M, Ribera A, Soriano A, Rodriguez-Pardo D, Sorli L, et al. Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study. Clin Microbiol Infect. 2016; 22(8): 732.e1-8. doi: 10.1016/j.cmi.2016.05.004
43. Peel TN, Cheng AC, Buising KL, Choong PF. Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective? Antimicrob Agents Chemother. 2012; 56(5): 2386-91. doi: 10.1128/AAC.06246-11
44. Lamagni T, Elgohari S, Harrington P. Trends in surgical site infections following orthopaedic surgery. Curr Opin Infect Dis. 2015; 28(2): 125-32. doi: 10.1097/QCO.0000000000000143
45. Thanni LO, Osinupebi OA, Deji-Agboola M. Prevalence of bacterial pathogens in infected wounds in a tertiary hospital, 1995-2001: any change in trend? J Natl Med Assoc. 2003; 95(12): 1189-95.
46. Glass GE, Barrett SP, Sanderson F, Pearse MF, Nanchahal J. The microbiological basis for a revised antibiotic regimen in high-energy tibial fractures: preventing deep infections by nosocomial organisms. J Plast Reconstr Aesthet Surg. 2011; 64(3): 375-80. doi: 10.1016/j.bjps.2010.05.037

Abstract   |   Reference